Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – 9,10-seco- cyclopentanohydrophenanthrene ring system doai
Patent
1995-05-05
1996-12-17
Prior, Kimberly J.
Drug, bio-affecting and body treating compositions
Designated organic active ingredient containing
9,10-seco- cyclopentanohydrophenanthrene ring system doai
A61K 3159
Patent
active
055853692
ABSTRACT:
The present invention is directed toward the use of 20-epi-vitamin D.sub.3 analogs to treat low bone turnover osteoporosis. The 20-epi compounds are characterized by a marked intestinal calcium transport activity while exhibiting much higher activity than 1.alpha.,25-dihydroxyvitamin D.sub.3 in their ability to mobilize calcium from bone.
REFERENCES:
patent: 4421690 (1983-12-01), Partridge et al.
patent: 4590184 (1986-05-01), Maeda et al.
patent: 4594432 (1986-06-01), Baggiolini et al.
patent: 4613594 (1986-09-01), Baggiolini et al.
patent: 4851401 (1989-07-01), DeLuca et al.
patent: 4929609 (1990-05-01), Batcho et al.
patent: 5247104 (1993-09-01), DeLuca et al.
patent: 5393749 (1995-02-01), DeLuca et al.
patent: 5401731 (1995-03-01), Calverley et al.
patent: 5401732 (1995-03-01), Calverley et al.
patent: 5446034 (1995-08-01), Bretting et al.
patent: 5447924 (1995-09-01), Bretting
patent: 5449668 (1995-09-01), Sestelo
Calverley, et al "Vitamin D" in Antitumor Steroids by R. T. Blickenstaff (1992) pp. 193-270.
DeLuca Hector F.
Wicha Jerzy
Prior Kimberly J.
Wisconsin Alumni Research Foundation
LandOfFree
Method of treating low bone turnover osteoporosis with (205) vit does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Method of treating low bone turnover osteoporosis with (205) vit, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Method of treating low bone turnover osteoporosis with (205) vit will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-1991457